The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAccrol Gp Regulatory News (ACRL)

Share Price Information for Accrol Gp (ACRL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 39.00
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.00 (0.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 39.00
ACRL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Launch of second ESG Report

28 Nov 2022 13:36

RNS Number : 8140H
Accrol Group Holdings PLC
28 November 2022
 

28 November 2022

 

Accrol Group Holdings plc

("Accrol" or the "Group")

 

Launch of second Environmental, Social and Governance Report

 

Accrol, the UK's leading independent tissue converter, is pleased to announce that it has today published its latest Environmental, Social and Governance ("ESG") Report, which is available on the Group's website: https://www.accrol.co.uk/esg/  

 

Gareth Jenkins, Chief Executive Officer of Accrol, said:

 

"Since the launch of our maiden ESG report a year ago, Accrol's ESG agenda has become even more integral to how we do business. Our approach to ESG makes clear the KPIs and measures we've set ourselves, so our stakeholders understand how our ESG framework shapes performance and the standards set.

 

It enables us to stay focused on long-term sustainable commercial success not just short-term return. It's great to share some of these examples with you in this year's report."

 

Key report highlights

 

Environmental performance:

· 15% reduction in tissue waste

· 3% reduction in energy use

· 8% reduction in carbon emissions and still a business in growth

· 15% more rolls per journey achieved removing c.12% trucks off the road

 

Social performance:

· Living Wage accredited employer - the only accredited UK tissue manufacturer

· Zero lost-time accidents

· Engaged workforce with 89% colleagues proud to work for Accrol

· 22% of females in leadership roles (+6% vs 2020)

 

Governance performance:

· All sites A or AA BRCGS accredited providing trusted reassurance to leading retailers

· Compliant Sedex member supporting responsible and sustainable business and supply chain decisions

· Supplier code of conduct launched

 

This announcement has been released as a Reach announcement.

 

For further information, please contact:

 

 

Accrol Group Holdings plc

Dan Wright, Executive Chairman

Via Belvedere Communications

Gareth Jenkins, Chief Executive Officer

Richard Newman, Chief Financial Officer

 

Belvedere Communications Limited

Cat Valentine

Tel: +44 (0) 7715 769 078

Keeley Clarke

Tel: +44 (0) 7967 816 525

accrolpr@belvederepr.com

 

Overview of Accrol

 

Accrol Group Holdings plc is a leading tissue converter and supplier of toilet tissues, kitchen rolls, facial tissues, and wet wipes to many of the UK's leading discounters and grocery retailers across the UK. The Group now operates from six manufacturing sites, including four in Lancashire, which now supplies 21.5% (volume) of the UK tissue market valued at £2.1bn at retail sales value.

 

The Group has produced a short video to showcase its operations and investment in the extensive automation of the business. Click here: Accrol Today.

 

For more information, please visit www.accrol.co.uk

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRABXBDBXXDDGDI
Date   Source Headline
18th May 20219:06 amRNSSecond Price Monitoring Extn
18th May 20219:00 amRNSPrice Monitoring Extension
18th May 20217:00 amRNSTrading Update
9th Apr 20217:00 amRNSAcquisition of highly scalable wet wipes business
8th Apr 20216:04 pmRNSCorrection: TR-1
8th Apr 20215:58 pmRNSCorrection: TR-1
30th Mar 20217:00 amRNSTR-1
18th Mar 20213:23 pmRNSTR-1
5th Mar 20217:11 amRNSImplementation of LTIP and PDMR dealing
14th Jan 20217:00 amRNSPDMR Dealings
12th Jan 20217:00 amRNSHalf Year Results
7th Jan 20217:00 amRNSOnline HY 21 Investor Presentation
17th Dec 20207:00 amRNSNotice of Half Year Results
15th Dec 20207:00 amRNSOnline Investor Presentation
14th Dec 202011:05 amRNSSecond Price Monitoring Extn
14th Dec 202011:00 amRNSPrice Monitoring Extension
14th Dec 20209:05 amRNSSecond Price Monitoring Extn
14th Dec 20209:00 amRNSPrice Monitoring Extension
11th Dec 20208:51 amRNSTR-1
2nd Dec 20207:00 amRNSAppointment of Chief Financial Officer
27th Nov 202012:48 pmRNSTR-1
26th Nov 20207:00 amRNSTR-1
25th Nov 20207:00 amRNSCompletion of Acquisition
24th Nov 20201:54 pmRNSTR-1
24th Nov 20201:44 pmRNSTR-1
24th Nov 202011:28 amRNSTR-1
24th Nov 202010:54 amRNSTR-1
24th Nov 20207:00 amRNSPDMR Dealing
23rd Nov 20208:00 amRNSAdmission of Shares & Total Voting Rights
20th Nov 202011:32 amRNSResult of General Meeting
20th Nov 20207:00 amRNSResult of Open Offer
6th Nov 202011:55 amRNSTR-1
4th Nov 20205:13 pmRNSPosting of Circular
3rd Nov 20207:00 amRNSConfirmation of Successful Placing
2nd Nov 20204:59 pmRNSAcquisition and Launch of ABB
2nd Nov 20207:00 amRNSCOVID-19 Business Update
27th Oct 20202:44 pmRNSResult of AGM
25th Sep 20208:00 amRNSNotice of AGM and Posting of Accounts
2nd Sep 20207:00 amRNSAudited Final Results
25th Aug 20207:00 amRNSNotice of Results and Online Investor Presentation
22nd May 202012:40 pmRNSTR-1
21st May 20202:25 pmRNSTR-1
6th May 20207:00 amRNSTrading Update
25th Mar 202010:19 amRNSTR-1
23rd Mar 202011:35 amRNSTR-1
17th Mar 20207:00 amRNSAppointment of Joint Broker
4th Mar 20207:00 amRNSTR-1
3rd Mar 20209:41 amRNSTR-1
29th Jan 20207:00 amRNSDirector's Dealing
21st Jan 20209:13 amRNSTR-1

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.